-
Mashup Score: 3Prospective, Multicenter Registry to Assess Safety and Efficacy of Radial Access for Peripheral Artery Interventions - 6 month(s) ago
Radial access (RA) may offer advantages in peripheral interventions, but previous studies on this approach have been limited to retrospective or singl…
Source: www.sciencedirect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Balloon-Expandable Covered Stent to Superficial Femoral Artery - 7 month(s) ago
A 57-year-old woman with critical limb-threatening ischemia (CLTI) of the left lower leg underwent endovascular therapy. She had undergone a femoropopliteal (F-P) bypass for treatment of chronic total occlusion (CTO) of the superficial femoral artery (SFA) four years prior.
Source: www.hmpgloballearningnetwork.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
From the #PAD Topic Center: Balloon-Expandable Covered Stent to Superficial Femoral Artery Hiroto Tamura, MD, Kenichiro Yuba, MD, & Shingo Kurimoto, MD https://t.co/rBumNyZLCT #cardiotwitter #CLIFighters https://t.co/IfOhD4PZy7
-
-
Mashup Score: 0The Pot Calling the Kettle Black - 8 month(s) ago
So, I vividly remember a professor in medical school telling us the following story and asking: “Which physician is more culpable for the patient’s death? The trauma surgeon, who operates on a patient involved in a major trauma that has a 100% chance of dying without an emergent operation and a 90%
Source: www.linkedin.comCategories: Cardiologists1, Latest HeadlinesTweet-
https://t.co/oiP9byOiHw Great read and knowing that we take on challenging cases even when odds are not in our favor, but we try as the ultimate fate may be an amputation. Let’s work together, we all need each others expertise to better care for our patients. #clifighters
-
-
Mashup Score: 0CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI - 11 month(s) ago
The cohort could help generate evidence for quality measures indicative of better outcomes in various subgroups.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
Earlier revasc and better wound care could factor into a quality metric framework. #CLIfighters #SCAI2023 @ACFanaroff https://t.co/2rNa5YodKv
-
-
Mashup Score: 0PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI - 1 year(s) ago
(UPDATED) Rigorous patient selection is needed, as are longer-term data on functional outcomes, says Sahil Parikh.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
"We feel that deep-vein arterialization is a paradigm shift." @shishem @sahilparikhmd @OchsnerHealth #CLIFighters #CLTI https://t.co/6XsYZNboqy
-
-
Mashup Score: 0Optimal Endovascular Therapy for the Femoral Bifurcation - 1 year(s) ago
Eric C. Scott, MD: A Case of Directional Atherectomy and Drug-Coated Balloon Angioplasty
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Optimal Endovascular Therapy for the Femoral Bifurcation: A Case of Directional Atherectomy and Drug-Coated Balloon Angioplasty #CLIFighters, read this case report from @EricScottMD on the #PAD Topic Center: https://t.co/tIcUQ0Vdvh https://t.co/swdTGllFfS
-
-
Mashup Score: 1Peripheral Arterial Disease - 1 year(s) ago
Topic Center Peripheral Arterial Disease from Cath Lab Digest including Case Report Case Report and Brief Review Case Report and Interview
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#CLIFighters, don’t miss these highlights from the CLD #PAD Topic Center: • CFA Anatomy & Relations to Bony Landmarks: A CTA Study  • 6 Limb-Saving Lessons Learned by PAD Patient Champions • PAD Care at OhioHealth with John A. Phillips, MD https://t.co/V6RSrYEcrz https://t.co/xuiHly2yx9
-
-
Mashup Score: 0Superficial Femoral Artery Endovascular Therapy: 12-Month Primary Patency Rates of Contemporary Endovascular Devices from 25,051 Patients - 1 year(s) ago
Approximately 5.8 million people experience peripheral arterial disease (PAD) in the United States today. Superficial femoral artery (SFA) disease is the most common cause of symptomatic PAD. New-generation nitinol stents, drug-coated stents, drug-coated balloons (DCB), covered stents, and directional or orbital atherectomy devices have shown promising results. However, clinical equipoise…
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Read the latest from CLD's #PAD Topic Center: SFA Endovascular Therapy: 12-Month Primary Patency Rates of Contemporary Endovascular Devices from 25,051 Patients https://t.co/kwQljJct4i #CLIFighters @InvasiveCardiol @hmpVDM
-
-
Mashup Score: 0Clinical Studies Show Medtronic Drug-Coated Balloon Outperforms Bare Metal Stents; Maintains Performance in Real World - 1 year(s) ago
Medtronic announced the results of two clinical studies on the use of the IN.PACT™ Admiral™ drug-coated PTA balloon catheter (DCB). These results were presented in late-breaking clinical trial sessions at VIVA 2022 in Las Vegas.
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
From CLD's #PAD Topic Center: Clinical Studies Show Medtronic IN.PACT Admiral Drug-Coated PTA Balloon Catheter Outperforms Bare Metal Stents; Maintains Performance in Real World Read more here: https://t.co/Tl36ooDSzg #CLIFighters #CardioTwitter https://t.co/ebc0r0BhmB
-
-
Mashup Score: 0Abstracts From the Amputation Prevention Symposium (AMP), August 17-20, 2022, Chicago, Illinois - 1 year(s) ago
Read the abstracts that were submitted to AMP, which took place August 17-20, 2022, in Chicago, Illinois. These abstracts cover a variety of topics, with a focus on PAD, CLI, and amputation prevention.
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
From the CLD #PAD Topic Center: Don’t miss these lower-extremity disease interventional abstracts featured at AMP 2022! https://t.co/y9oJnuUnwg #CLIFighters #cardiotwitter https://t.co/G8aKEUA8g8
-
🆕📖 Prospective & multicenter registry to assess safety & efficacy of radial access for #PAD. 💡RA allowed for early ambulation & same-day discharge for most patients w no serious adverse events. #RadialFirst #CLIFighters ➡️ https://t.co/Vsj5gqnelb https://t.co/V4sEgB7MNO